These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 16193978)
1. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium. Wu L; Diao Z; Deng X; Gao J; Zhou Z; Liu Y; Wang Y J Nanosci Nanotechnol; 2005 Aug; 5(8):1204-10. PubMed ID: 16193978 [TBL] [Abstract][Full Text] [Related]
2. Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Toledo A; Larralde C; Fragoso G; Gevorkian G; Manoutcharian K; Hernández M; Acero G; Rosas G; López-Casillas F; Garfias CK; Vázquez R; Terrazas I; Sciutto E Infect Immun; 1999 May; 67(5):2522-30. PubMed ID: 10225916 [TBL] [Abstract][Full Text] [Related]
3. Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Toledo A; Fragoso G; Rosas G; Hernández M; Gevorkian G; López-Casillas F; Hernández B; Acero G; Huerta M; Larralde C; Sciutto E Infect Immun; 2001 Mar; 69(3):1766-73. PubMed ID: 11179354 [TBL] [Abstract][Full Text] [Related]
4. Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen. Bobes RJ; Navarrete-Perea J; Ochoa-Leyva A; Anaya VH; Hernández M; Cervantes-Torres J; Estrada K; Sánchez-Lopez F; Soberón X; Rosas G; Nunes CM; García-Varela M; Sotelo-Mundo RR; López-Zavala AA; Gevorkian G; Acero G; Laclette JP; Fragoso G; Sciutto E Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28923896 [No Abstract] [Full Text] [Related]
5. Optimized codon usage enhances the expression and immunogenicity of DNA vaccine encoding Taenia solium oncosphere TSOL18 gene. Wang YY; Chang XL; Tao ZY; Wang XL; Jiao YM; Chen Y; Qi WJ; Xia H; Yang XD; Sun X; Shen JL; Fang Q Mol Med Rep; 2015 Jul; 12(1):281-8. PubMed ID: 25738605 [TBL] [Abstract][Full Text] [Related]
9. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Guo YJ; Sun SH; Zhang Y; Chen ZH; Wang KY; Huang L; Zhang S; Zhang HY; Wang QM; Wu D; Zhu WJ Vaccine; 2004 Sep; 22(29-30):3841-7. PubMed ID: 15364430 [TBL] [Abstract][Full Text] [Related]
11. Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis. Gevorkian G; Manoutcharian K; Larralde C; Hernandez M; Almagro JC; Viveros M; Sotelo J; Garcia E; Sciutto E Immunol Lett; 1996 Mar; 49(3):185-9. PubMed ID: 8739315 [TBL] [Abstract][Full Text] [Related]
12. Protective immunity against Taenia crassiceps murine cysticercosis induced by DNA vaccination with a Taenia saginata tegument antigen. Rosas G; Fragoso G; Garate T; Hernández B; Ferrero P; Foster-Cuevas M; Parkhouse RM; Harrison LJ; Briones SL; González LM; Sciutto E Microbes Infect; 2002 Nov; 4(14):1417-26. PubMed ID: 12475632 [TBL] [Abstract][Full Text] [Related]
13. Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Wang QM; Sun SH; Hu ZL; Wu D; Wang ZC Vaccine; 2003 Apr; 21(15):1672-80. PubMed ID: 12639489 [TBL] [Abstract][Full Text] [Related]
14. Protection from murine cysticercosis by immunization with a parasite cysteine protease. Baig S; Damian RT; Morales-Montor J; Ghaleb A; Baghdadi A; White AC Microbes Infect; 2006 Oct; 8(12-13):2733-5. PubMed ID: 16979365 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the protective potential of a Taenia solium cysticercus mimotope on murine cysticercosis. Capelli-Peixoto J; Chávez-Olórtegui C; Chaves-Moreira D; Minozzo JC; Gabardo J; Teixeira KN; Thomaz-Soccol V; Alvarenga LM; de Moura J Vaccine; 2011 Nov; 29(51):9473-9. PubMed ID: 22027483 [TBL] [Abstract][Full Text] [Related]
16. Expression of Multiple Taenia Solium Immunogens in Plant Cells Through a Ribosomal Skip Mechanism. Monreal-Escalante E; Bañuelos-Hernández B; Hernández M; Fragoso G; Garate T; Sciutto E; Rosales-Mendoza S Mol Biotechnol; 2015 Jul; 57(7):635-43. PubMed ID: 25761936 [TBL] [Abstract][Full Text] [Related]
17. Peptide epitopes of the Taenia solium antigen Ts8B2 are immunodominant in human and porcine cysticercosis. Ferrer E; Martínez-Escribano JA; Barderas ME; González LM; Cortéz MM; Dávila I; Harrison LJ; Parkhouse RM; Gárate T Mol Biochem Parasitol; 2009 Dec; 168(2):168-71. PubMed ID: 19712705 [TBL] [Abstract][Full Text] [Related]
18. Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis. Deckers N; Saerens D; Kanobana K; Conrath K; Victor B; Wernery U; Vercruysse J; Muyldermans S; Dorny P Int J Parasitol; 2009 Apr; 39(5):625-33. PubMed ID: 19041315 [TBL] [Abstract][Full Text] [Related]
19. Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin. Solís CF; Ostoa-Saloma P; Lugo-Martínez VH; Johnston SA; Laclette JP Infect Immun; 2005 Mar; 73(3):1895-7. PubMed ID: 15731096 [TBL] [Abstract][Full Text] [Related]
20. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination. Guo A; Jin Z; Zheng Y; Hai G; Yuan G; Li H; Cai X Vaccine; 2007 Jan; 25(1):170-5. PubMed ID: 16750874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]